Esperion Therapeutics (ESPR)
(Delayed Data from NSDQ)
$1.63 USD
-0.05 (-2.98%)
Updated Sep 23, 2024 03:59 PM ET
Pre-Market: $1.65 +0.02 (1.23%) 8:46 AM ET
3-Hold of 5 3
C Value A Growth C Momentum A VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/05/2024
Time: -- |
9/2024 | $-0.14 | 0.00% |
Earnings Summary
For their last quarter, Esperion Therapeutics (ESPR) reported earnings of -$0.05 per share, beating the Zacks Consensus Estimate of $-0.15 per share. This reflects a positive earnings surprise of 66.67%. Look out for ESPR's next earnings release expected on November 05, 2024. For the next earning release, we expect the company to report earnings of -$0.14 per share, reflecting a year-over-year increase of 62.16%.
Earnings History
Price & Consensus
Zacks News for ESPR
Esperion's (ESPR) Q2 Loss Narrows, Revenues Soar Year Over Year
ESPR: What are Zacks experts saying now?
Zacks Private Portfolio Services